Back to Results
First PageMeta Content



GMI-1271, a Potent E-Selectin Antagonist, in Combination with Chemotherapy in Relapsed/Refractory AML: A Novel, Well-Tolerated Regimen with a High Remission Rate Daniel J. DeAngelo*1, Brian A. Jonas2, Jane L. Liesveld3,
Add to Reading List

Document Date: 2017-06-26 08:58:58

Open Document

File Size: 729,11 KB

Share Result on Facebook
UPDATE